Endimiani, Andrea; Jacobs, Michael R (2016). The Changing Role of the Clinical Microbiology Laboratory in Defining Resistance in Gram-negatives. Infectious disease clinics of North America, 30(2), pp. 323-345. Elsevier 10.1016/j.idc.2016.02.002
Text
Endimiani-Jacobs IDCNA-final.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (228kB) |
The evolution of resistance in Gram-negatives has challenged the clinical microbiology laboratory to implement new methods for their detection. Multidrug-resistant strains present major challenges to conventional and new detection methods. More rapid pathogen identification and antimicrobial susceptibility testing have been developed for use directly on specimens, including fluorescence in situ hybridization tests, automated polymerase chain reaction systems, microarrays, mass spectroscopy, next-generation sequencing, and microfluidics. Review of these methods shows the advances that have been made in rapid detection of resistance in cultures, but limited progress in direct detection from specimens.
Item Type: |
Journal Article (Review Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Service Sector > Institute for Infectious Diseases |
UniBE Contributor: |
Endimiani, Andrea |
Subjects: |
500 Science > 570 Life sciences; biology 600 Technology > 610 Medicine & health |
ISSN: |
0891-5520 |
Publisher: |
Elsevier |
Funders: |
[4] Swiss National Science Foundation |
Projects: |
[577] SNF project 153377 to Andrea Endimiani |
Language: |
English |
Submitter: |
Andrea Endimiani |
Date Deposited: |
06 Jan 2017 14:55 |
Last Modified: |
05 Dec 2022 15:00 |
Publisher DOI: |
10.1016/j.idc.2016.02.002 |
PubMed ID: |
27208762 |
Web of Science ID: |
000378466900003 |
Uncontrolled Keywords: |
AST; LAMP; MALDI-TOF; Microarray; PCR; Rapid; Real time; Sequencing |
BORIS DOI: |
10.7892/boris.91231 |
URI: |
https://boris.unibe.ch/id/eprint/91231 |